Navigation Links
HIV survival improves if patients stay in care

People with HIV who drop out of care do not live as long as those who remain under a doctor's treatment, said Baylor College of Medicine and Veterans Affairs researchers in a report published in the June 1 issue of Clinical Infectious Diseases and available on line.

"In an era when highly active therapy directed against HIV (the human immunodeficiency virus that causes AIDS) is keeping people alive, understanding the value of regular medical care is crucial," said Dr. Thomas Giordano, assistant professor of medicine ?infectious diseases at BCM and lead author of the report.

"We know that adherence to medications is critically important," said Giordano. "Patients who have trouble taking their medicines regularly will do less well. But what about those people who aren't even seeing a doctor regularly" Before this study, we had only a vague understanding of the magnitude of the problem, and we certainly didn't know whether it affected survival."

While HIV is now a chronic or lifelong disease, it is one that typically strikes at a relatively young age. That makes the population different from those who have high blood pressure or adult-onset diabetes.

"These patients often have a lot of other things going on. They are young. Often, they face challenges of substance abuse, mental health problems and financial issues. Now they have to stay in care the rest of their lives, which may be 20, 30, 40 or more years."

Giordano's study, carried out in the Veterans Affairs population, determined that staying in care made a difference to longevity. Studying those in the VA population eliminated the issue of ability to pay for care, enabling him and his colleagues to look at care alone.

Giordano and his colleagues looked at 2,619 men with HIV for more than four years. Most were diagnosed between 1997-1998 at a VA hospital or clinic and began treatment after Jan. 1, 1997.

Researchers divided the men into four gro ups based on the number of quarters in the first year after starting treatment that they visited their HIV physicians or health care provider. Sixty-four percent of them had at least one visit in all four quarters, 18 percent in three of four quarters, 11 percent in two of four quarters and 6 percent in only one quarter. The researchers then looked at how long the patients survived after that first year.

Sixteen percent of the patients died. Those who had poorer retention in care or visited the physicians less during the year after starting treatment had a greater risk of dying than those who saw the physicians at least once each quarter. Patients with visits in one quarter had nearly twice the risk of dying compared to patients with visits in all four quarters.

"The next step is to figure out how to get them to stay in care," said Giordano. He plans to look for ways to intervene in this process. He is now studying a group of people who are newly diagnosed with HIV in Houston to evaluate the effects of knowledge about the disease socioeconomics, and other factors on retention in care.


'"/>

Source:Baylor College of Medicine


Related biology news :

1. The Bacterias guide to survival
2. Boosting HIV screening can increase survival and is cost effective
3. Researchers identify protein crucial for survival of Lyme-disease bacterium
4. Novel protein complex enables survival in hostile environment
5. BiovaxID?yields 89 percent survival in patients with aggressive non-Hodgkins
6. UCI researchers discover key factor for survival of human embryonic stem cells
7. Rhinos clinging to survival in the heart of Borneo, despite poaching
8. DNA: Bacterias survival ration
9. New research promising for improving brain cell survival after brain injury
10. AIDS vaccine research offers new insights on survival
11. New path from estrogen to survival in breast cancer cells described
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its quarter and year ended December 31, 2016. ... million compared to $6.9 million in the same quarter last ... $0.6 million compared to $2.6 million in the fourth quarter ... was $0.5 million, or $0.02 per diluted share, which compares ...
(Date:2/8/2017)... -- Report Highlights The global biosurgery market ... in 2016 at a compound annual growth rate (CAGR) ... - An overview of the global market for biosurgery. ... 2015 and 2016, and projections of compound annual growth ... on the basis of product type, source, application, and ...
(Date:2/7/2017)... 2017 Ipsidy Inc. ( www.ipsidy.com ... IDGS], ("Ipsidy" or the "Company") a provider of secure, ... is pleased to announce the following changes as part ... January 31, 2017, Philip D. Beck was ... President.  An experienced payment industry professional and public company ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Corporation (NASDAQ: VWR), the leading global independent provider of product ... its financial results for the fourth quarter and full year ... 4Q16 record quarterly net sales of $1.13 billion, up ... 4Q16 EMEA-APAC segment net sales increased ... net sales increased 2.5%, or down 0.9% on an organic ...
(Date:2/23/2017)... Feb. 23, 2017 /PRNewswire/ - The Fight Against Cancer ... Research (OICR) are pleased to report that Fusion Pharmaceuticals ... with Johnson & Johnson Innovation – JJDC, Inc. (JJDC) ... groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, as ... ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... de novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® Seizure ... at home or in healthcare facilities during periods of rest. A lightweight, non-invasive ...
Breaking Biology Technology: